Literature DB >> 25832682

Relating proton treatments to photon treatments via the relative biological effectiveness-should we revise current clinical practice?

Harald Paganetti1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25832682     DOI： 10.1016/j.ijrobp.2014.11.021

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  15 in total

Review 1.  Proton RBE dependence on dose in the setting of hypofractionation.

Authors:  Thomas Friedrich
Journal:  Br J Radiol       Date:  2019-08-28       Impact factor: 3.039

Review 2.  Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives.

Authors:  Gyu Sang Yoo; Jeong Il Yu; Hee Chul Park
Journal:  World J Gastroenterol       Date:  2018-07-28       Impact factor: 5.742

Review 3.  Modelling variable proton relative biological effectiveness for treatment planning.

Authors:  Aimee McNamara; Henning Willers; Harald Paganetti
Journal:  Br J Radiol       Date:  2019-11-18       Impact factor: 3.039

4.  A phenomenological relative biological effectiveness (RBE) model for proton therapy based on all published in vitro cell survival data.

Authors:  Aimee L McNamara; Jan Schuemann; Harald Paganetti
Journal:  Phys Med Biol       Date:  2015-10-13       Impact factor: 3.609

5.  Proton Relative Biological Effectiveness - Uncertainties and Opportunities.

Authors:  Harald Paganetti
Journal:  Int J Part Ther       Date:  2018-09-21

6.  Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.

Authors:  Vijay P Raturi; Hidehiro Hojo; Kenji Hotta; Hiromi Baba; Ryo Takahashi; Toshiya Rachi; Naoki Nakamura; Sadamoto Zenda; Atsushi Motegi; Hidenobu Tachibana; Takaki Ariji; Kana Motegi; Masaki Nakamura; Masayuki Okumura; Yasuhiro Hirano; Tetsuo Akimoto
Journal:  Radiat Oncol       Date:  2020-06-22       Impact factor: 3.481

7.  Targeting DNA-dependent protein kinase sensitizes hepatocellular carcinoma cells to proton beam irradiation through apoptosis induction.

Authors:  Changhoon Choi; Arang Son; Ga-Haeng Lee; Sung-Won Shin; Sohee Park; Sang Hee Ahn; Yoonsun Chung; Jeong Il Yu; Hee Chul Park
Journal:  PLoS One       Date:  2019-06-13       Impact factor: 3.240

8.  Proton Therapy For Lymphomas: Current State Of The Art.

Authors:  Umberto Ricardi; Maja V Maraldo; Mario Levis; Rahul R Parikh
Journal:  Onco Targets Ther       Date:  2019-10-01       Impact factor: 4.147

9.  Checkpoint Kinase 1 (CHK1) Inhibition Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Proton Irradiation via Rad51 Downregulation.

Authors:  Changhoon Choi; Won Kyung Cho; Sohee Park; Sung-Won Shin; Won Park; Haeyoung Kim; Doo Ho Choi
Journal:  Int J Mol Sci       Date:  2020-04-13       Impact factor: 5.923

10.  Intensity-modulated ventricular irradiation for intracranial germ-cell tumors: Survival analysis and impact of salvage re-irradiation.

Authors:  Ana Carolina Pires de Rezende; Eduardo Weltman; Michael Jenwei Chen; Juliana Karassawa Helito; Ícaro Thiago de Carvalho; Roberto Kenji Sakuraba; Nasjla Saba Silva; Andrea Maria Cappellano; Nelson Hamerschlak
Journal:  PLoS One       Date:  2019-12-20       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.